Quantification and Characterisation of Fluctuating Cognition in Dementia with Lewy Bodies and Alzheimer’s Disease

Fluctuating cognition (FC) is a common and important symptom in dementia, particularly dementia with Lewy bodies (DLB), although it has not been empirically quantified or characterised. Forty subjects (15 DLB, 15 AD, 10 elderly controls) were evaluated using a clinical FC severity scale, as well as receiving measures of variability in attentional performance and slow EEG rhythms across 90 s, 1 h and 1 week. DLB patients had significantly more severe FC and more severe variability in attentional and slow electrocortical measures than either AD patients or normal controls in all time frames. Attentional and EEG variability also correlated significantly with independent clinical ratings of FC. Clinical quantification and measures of attention and EEG variability can therefore make an important and standardised contribution to the assessment of FC in dementia, facilitating future treatment studies with important implications for the potential causative mechanisms and differential diagnosis.

[1]  E. Perry,et al.  Operational criteria for senile dementia of Lewy body type (SDLT) , 1992, Psychological Medicine.

[2]  P. Lantos,et al.  Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies , 1999, British Journal of Psychiatry.

[3]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[4]  W. Kirch,et al.  Effects of physostigmine on scopolamine–induced changes in quantitative electroencephalogram and cognitive performance , 1998 .

[5]  G. Halliday,et al.  Diffuse Lewy body disease: clinical features in nine cases without coexistent Alzheimer's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[6]  H. Kolbeinsson,et al.  Delirium and dementia in acute medical admissions of elderly patients in Iceland , 1993, Acta psychiatrica Scandinavica.

[7]  K. Jellinger,et al.  Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. , 1998, Archives of neurology.

[8]  Z Walker,et al.  Neuropsychological performance in Lewy body dementia and Alzheimer's disease , 1997, British Journal of Psychiatry.

[9]  T. Imai,et al.  A Case of Diffuse Lewy Body and Alzheimer's Diseases with Periodic Synchronous Discharges , 1988, Journal of neuropathology and experimental neurology.

[10]  A. Burns,et al.  New drugs for Alzheimer's disease , 1999, British Journal of Psychiatry.

[11]  M. Norenberg,et al.  Diffuse Lewy body disease and progressive dementia , 1988, Neurology.

[12]  E. Perry,et al.  Acetylcholine in mind: a neurotransmitter correlate of consciousness? , 1999, Trends in Neurosciences.

[13]  E. Perry,et al.  Neuroleptic sensitivity in patients with senile dementia of Lewy body type. , 1992, BMJ.

[14]  S Fahn,et al.  Committee. Unified Parkinson’s Disease Rating Scale. , 2001 .

[15]  L. Wolfson,et al.  Antemortem diagnosis of diffuse Lewy body disease , 1990, Neurology.

[16]  K. Marder,et al.  The Columbia University Scale for Psychopathology in Alzheimer's disease. , 1992, Archives of neurology.

[17]  Second Edition,et al.  Statistical Package for the Social Sciences , 1970 .

[18]  R. H. Perry,et al.  Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness , 1995, Brain and Cognition.

[19]  J. Copeland,et al.  Computerized diagnosis from a standardized history schedule: A preliminary communication about the organic section of the HAS–AGECAT system , 1992 .

[20]  D. Dickson,et al.  Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy‐verified sample , 1999, International journal of geriatric psychiatry.

[21]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[22]  R. Godwin-Austen,et al.  Diffuse Lewy body disease: clinical features in 15 cases. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[23]  S. Fahn.  Unified Parkinson's Disease Rating Scale , 1987 .

[24]  D. Bachman,et al.  Neuropsychological features of diffuse Lewy body disease. , 1996, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[25]  I G McKeith,et al.  EEG findings in dementia with Lewy bodies and Alzheimer’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[26]  E. Mori.  [Dementia with Lewy bodies]. , 2000, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[27]  M. L. Plume,et al.  SPSS (Statistical Package for the Social Sciences) , 2002, Encyclopedia of Information Systems.

[28]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[29]  Hitoshi Takahashi,et al.  Clinical features of familial diffuse Lewy body disease. , 1997, European neurology.

[30]  R. N. Mohan,et al.  Idiopathic clouding of consciousness—do the patients have cortical lewy body disease? , 1993 .

[31]  K. Blennow,et al.  Delirium in dementia , 1998, International journal of geriatric psychiatry.

[32]  G. Dumermuth,et al.  EEG-based multivariate statistical analysis of sleep stages. , 1984, Neuropsychobiology.

[33]  I. McKeith,et al.  Neuroleptic sensitivity to risperidone in Lewy body dementia , 1995, The Lancet.

[34]  Keith Wesnes,et al.  The cognitive drug research computerized assessment system for demented patients: A validation study , 1991 .

[35]  J. Grace,et al.  Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease , 1998, The Lancet.

[36]  W. Gibb,et al.  Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). , 1987, Brain : a journal of neurology.